Laura Alder, MD, discusses clinical decision-making around prioritizing local vs systemic therapy for patients with lung cancer who present with CNS-only metastatic disease.
Laura Alder, MD
Advertisement
Laura Alder, MD is a medical oncologist with Duke Cancer Center.
Articles by Laura Alder, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Gedatolisib for HR+, HER2-Negative Advanced Breast Cancer
2
Adjuvant CDK4/6 Inhibitors Gain Ground as Oral SERDs Emerge to Tackle Endocrine Resistance in Early HR+ Breast Cancer
3
Gamgertamig Nets FDA Fast Track Designation in Autoimmune Hemolytic Anemia and Immune Thrombocytopenia
4
Mezigdomide-Based Triplet Highlights Potential of CELMoDs in Myeloma Management
5